Heidelberg Pharma Trading Update (24 h Ending 22 Oct 2026)
Price movement Heidelberg Pharma (HPHA.DE) closed 2.7 % lower at 10:23 PM Central Europe on Thursday 22 Oct 2026. Current trading price is approximately EUR 1.98 on major exchanges.
Market data
Current supply: 46.8 million shares.
Market capitalization: EUR 98.7 million.
Volume traded in the last 24 hours: EUR 5.8 k.
200‑day simple moving average: EUR 2.71.
52‑week high: EUR 3.34 (recorded 1 Sep 2026).
52‑week low: EUR 2.11 (recorded 21 Oct 2026).
Year‑to‑date performance (since last month‑end): 14.62 % decline.
Comparative Performance of Related Stocks (Last 24 h)
| Symbol | Change | Current Price | Market Cap (EUR m) |
|---|---|---|---|
| KTA.DE | +4.14 % | 9.7 | 98.9 |
| MXHN.DE | +0.4 % | 2.45 | 101.9 |
| PYR.F | –1.82 % | 25.9 | 107.7 |
| EDL.DE | +0.43 % | 4.6 | 99.6 |
| MUT.SG | 0 % | 14.1 | 113.4 |
Additional ratios
- EDL.DE: P/E = 7.5
- MUT.SG: P/E = 21.16
Company Overview
Heidelberg Pharma AG is a German biopharmaceutical firm that focuses on developing and commercializing novel cancer therapies. The company also conducts research in pharmacology, drug metabolism, pharmacokinetics, and molecular biology, targeting oncology and inflammatory diseases. Heidelberg Pharma serves patients and healthcare professionals within Germany. The company trades on the Xetra stock exchange. Its IPO was held on 13 November 2006. For further information, visit www.heidelberg-pharma.com .
